South San Francisco, United States: innovation profile
South San Francisco is number 190 in the 311 Innovation Cities Index, with an innovation score of 30. It is home to 2 R&D labs, 24 startups and 2 investors in the 311 Institute directories.
Part of the 311 Innovation Cities Index (311institute.com). Last updated .
#190Rank
30Innovation score
2R&D labs
24Startups
2Investors
0Titans
0Unicorns
Startups
- Addition Therapeutics
- Asher Biotherapeutics
- Burnbot
- Dualitas Therapeutics
- Firefly Bio
- Kamau Therapeutics
- Long Bridge Medical
- Lycia Therapeutics
- Mahzi Therapeutics
- Moonwalk Biosciences
- NGM Bio Holdings
- NewLimit
- Noetik
- PandaDoc
- Purism
- Rila Therapeutics
- Sequome
- Seranova Bio
- Shenandoah Therapeutics
- SonoThera
- Spirair
- Synlico
- TRex Holdings
- Terremoto Biosciences
Investors
R&D labs
Johnson & Johnson (United States), Roche.